BSD Medical Reports On Continued Sales Momentum By Terumo BCT For The Microthermx® Microwave System

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

SALT LAKE CITY--(BUSINESS WIRE)--BSD Medical Corporation (NASDAQ:BSDM) (Company or BSD) (www.BSDMedical.com), a leading provider of medical systems that treat cancer and benign diseases using heat therapy, today reported continued sales momentum by Terumo on the distribution of the MicroThermX® Microwave Ablation System (MicroThermX). BSD’s exclusive, multimillion dollar agreement with Terumo Europe NV (Terumo) covers distribution of the MicroThermX in more than 100 countries, including Europe, Western Asia and Africa, with a market potential that exceeds $1 billion.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC